Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Head and Neck Cancer

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 53 articles:
HTML format



Single Articles


    April 2020
  1. SHETE S, Liu H, Wang J, Yu R, et al
    A genome-wide association study identifies two novel susceptible regions for squamous cell carcinoma of the head and neck.
    Cancer Res. 2020 Apr 10. pii: 0008-5472.CAN-19-2360.
    PubMed     Abstract available


    March 2020
  2. WU S, Zhang L, Deng J, Guo B, et al
    A Novel Micropeptide Encoded by Y-Linked LINC00278 Links Cigarette Smoking and AR Signaling in Male Esophageal Squamous Cell Carcinoma.
    Cancer Res. 2020 Mar 13. pii: 0008-5472.CAN-19-3440.
    PubMed     Abstract available


    February 2020
  3. JIANG C, Li L, Xiang YQ, Lung ML, et al
    Epstein-Barr Virus microRNA BART2-5p promotes metastasis of nasopharyngeal carcinoma by suppressing RND3.
    Cancer Res. 2020 Feb 14. pii: 0008-5472.CAN-19-0334.
    PubMed     Abstract available


  4. NAZARI F, Oklejas AE, Nor JE, Pearson AT, et al
    In silico models accurately predict in vivo response for IL-6 blockade in head and neck cancer.
    Cancer Res. 2020 Feb 10. pii: 0008-5472.CAN-19-1846.
    PubMed     Abstract available


    December 2019
  5. MIYAUCHI S, Sanders PD, Guram K, Kim SS, et al
    HPV16 E5 Mediates Resistance to PD-L1 Blockade and can be targeted with Rimantadine in Head and Neck Cancer.
    Cancer Res. 2019 Dec 17. pii: 0008-5472.CAN-19-1771.
    PubMed     Abstract available


  6. SEHGAL K, Barbie DA
    Clonal Selection Drives NF-kappaB Activation in Recurrent Nasopharyngeal Carcinoma.
    Cancer Res. 2019;79:5915-5916.
    PubMed     Abstract available


    September 2019
  7. YOU R, Liu YP, Lin DC, Li Q, et al
    Clonal Mutations Activate the NF-kappaB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma.
    Cancer Res. 2019 Sep 4. pii: 0008-5472.CAN-18-3845.
    PubMed     Abstract available


    July 2019
  8. ZHENG ZQ, Li ZX, Zhou GQ, Lin L, et al
    Long non-coding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and upregulate ITGB3.
    Cancer Res. 2019 Jul 22. pii: 0008-5472.CAN-19-0799.
    PubMed     Abstract available


  9. WU X, Yeerna H, Goto Y, Ando T, et al
    Metformin inhibits progression of Head and Neck Squamous Cell Carcinoma by acting Directly on Carcinoma Initiating Cells.
    Cancer Res. 2019 Jul 10. pii: 0008-5472.CAN-18-3525.
    PubMed     Abstract available


    April 2019
  10. PAIDI SK, Diaz PM, Dadgar S, Jenkins SV, et al
    Label-Free Raman Spectroscopy Reveals Signatures of Radiation Resistance in the Tumor Microenvironment.
    Cancer Res. 2019;79:2054-2064.
    PubMed     Abstract available


    March 2019
  11. WANG Z, Feng X, Molinolo AA, Martin D, et al
    4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.
    Cancer Res. 2019 Mar 20. pii: 0008-5472.CAN-18-1220.
    PubMed     Abstract available


  12. BHATIA S, Oweida A, Lennon S, Darragh LB, et al
    Inhibition of EphB4-ephrin-B2 signaling reprograms the tumor immune microenvironment in head and neck cancers.
    Cancer Res. 2019 Mar 20. pii: 0008-5472.CAN-18-3257.
    PubMed     Abstract available


  13. FAN S, Tian T, Chen W, Lv X, et al
    Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription.
    Cancer Res. 2019;79:1069-1084.
    PubMed     Abstract available


  14. ESPOSITO R, Esposito D, Ciccodicola A, Costa V, et al
    Oncogenic properties of the antisense lncRNA COMET in BRAF- and RET-driven papillary thyroid carcinomas.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-2520.
    PubMed     Abstract available


    December 2018
  15. ZHANG J, Li YQ, Guo R, Wang YQ, et al
    Hypermethylation of SHISA3 promotes nasopharyngeal carcinoma metastasis by reducing SGSM1 stability.
    Cancer Res. 2018 Dec 20. pii: 0008-5472.CAN-18-1754.
    PubMed     Abstract available


    September 2018
  16. BAIRD JR, Bell RB, Troesch V, Friedman DJ, et al
    Evaluation of explant responses to STING ligands: personalized immunosurgical therapy for head and neck squamous cell carcinoma.
    Cancer Res. 2018 Sep 17. pii: 0008-5472.CAN-18-1652.
    PubMed     Abstract available


  17. KAJIWARA C, Fumoto K, Kimura H, Nojima S, et al
    p63-dependent Dickkopf3 expression promotes esophageal cancer cell proliferation via CKAP4.
    Cancer Res. 2018 Sep 4. pii: 0008-5472.CAN-18-1749.
    PubMed     Abstract available


    August 2018
  18. KRISHNA S, Ulrich P, Wilson E, Parikh F, et al
    Human papilloma virus specific immunogenicity and dysfunction of CD8+ T cells in head and neck cancer.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0163.
    PubMed     Abstract available


  19. READ ML, Modasia B, Fletcher A, Thompson RJ, et al
    PTTG and PBF functionally interact with p53 and predict overall survival in head and neck cancer.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0855.
    PubMed     Abstract available


    July 2018
  20. DORTA-ESTREMERA S, Chin RL, Sierra G, Nicholas C, et al
    Mucosal HPV E6/E7 peptide vaccination in combination with immune checkpoint modulation induces regression of HPV+ oral cancers.
    Cancer Res. 2018 Jul 27. pii: 0008-5472.CAN-18-0892.
    PubMed     Abstract available


    June 2018
  21. ZHANG J, Chen T, Yang X, Cheng H, et al
    Attenuated TRAF3 fosters alternative activation of NF-kappaB and reduced expression of anti-viral interferon, TP53, and RB to promote HPV-positive head and neck cancers.
    Cancer Res. 2018 Jun 19. pii: 0008-5472.CAN-17-0642.
    PubMed     Abstract available


  22. BROUWER AF, Eisenberg MC, Meza R
    Case Studies of Gastric, Lung, and Oral Cancer Connect Etiologic Agent Prevalence to Cancer Incidence.
    Cancer Res. 2018;78:3386-3396.
    PubMed     Abstract available


    May 2018
  23. KUMAR D, New J, Vishwakarma V, Joshi R, et al
    Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression.
    Cancer Res. 2018 May 16. pii: 0008-5472.CAN-17-1076.
    PubMed     Abstract available


  24. GOU Q, Gao L, Nie X, Pu W, et al
    Long noncoding RNA AB074169 inhibits cell proliferation via modulation of KHSRP-mediated p21 expression in papillary thyroid carcinoma.
    Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-3766.
    PubMed     Abstract available


    March 2018
  25. KAAKOUSH NO
    Microbiome and Esophageal Adenocarcinoma-Letter.
    Cancer Res. 2018;78:1574.
    PubMed    


    February 2018
  26. BRAND TM, Hartmann S, Bhola NE, Li H, et al
    Crosstalk signaling between HER3 and HPV16 E6 and E7 mediates resistance to PI3K inhibitors in head and neck cancer.
    Cancer Res. 2018 Feb 12. pii: 0008-5472.CAN-17-1672.
    PubMed     Abstract available


  27. GROSSBERG AJ, Vichaya EG, Christian DL, Molkentine JM, et al
    Tumor-Associated Fatigue in Cancer Patients Develops Independently of IL1 Signaling.
    Cancer Res. 2018;78:695-705.
    PubMed     Abstract available


    December 2017

  28. Correction: JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.
    Cancer Res. 2017;77:7136.
    PubMed    


  29. ORLACCHIO A, Ranieri M, Brave M, Arciuch VA, et al
    SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance.
    Cancer Res. 2017;77:6914-6926.
    PubMed     Abstract available


  30. HU F, Martin H, Martinez A, Everitt J, et al
    Distinct Angiogenic Changes during Carcinogenesis Defined by Novel Label-Free Dark-Field Imaging in a Hamster Cheek Pouch Model.
    Cancer Res. 2017;77:7109-7119.
    PubMed     Abstract available


  31. GADHIKAR MA, Zhang J, Shen L, Rao X, et al
    CDKN2A/p16 deletion in head and neck cancer cells is associated with Cdk2 activation, replication stress, and vulnerability to Chk1 inhibition.
    Cancer Res. 2017 Dec 11. pii: 0008-5472.CAN-17-2802.
    PubMed     Abstract available


  32. PETERS BA, Wu J, Pei Z, Yang L, et al
    Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers.
    Cancer Res. 2017;77:6777-6787.
    PubMed     Abstract available


  33. KELLEY DZ, Flam EL, Izumchenko E, Danilova LV, et al
    Integrated Analysis of Whole-Genome ChIP-Seq and RNA-Seq Data of Primary Head and Neck Tumor Samples Associates HPV Integration Sites with Open Chromatin Marks.
    Cancer Res. 2017;77:6538-6550.
    PubMed     Abstract available


    October 2017
  34. SUGASE T, Takahashi T, Serada S, Fujimoto M, et al
    SOCS1 gene therapy improves radiosensitivity and enhances irradiation-induced DNA damage in esophageal squamous cell carcinoma.
    Cancer Res. 2017 Oct 17. pii: canres.1525.2017.
    PubMed     Abstract available


  35. GUO T, Sakai A, Afsari B, Considine M, et al
    A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers.
    Cancer Res. 2017;77:5248-5258.
    PubMed     Abstract available


    September 2017
  36. LI J, Yan S, Liu Z, Zhou Y, et al
    Multiregional sequencing reveals genomic alterations and clonal dynamics in primary malignant melanoma of the esophagus.
    Cancer Res. 2017 Sep 29. pii: canres.0938.2017.
    PubMed     Abstract available


  37. NEW J, Arnold L, Ananth M, Alvi S, et al
    Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target.
    Cancer Res. 2017 Sep 28. pii: canres.1077.2017.
    PubMed     Abstract available


  38. YUAN J, Jiang YY, Mayakonda A, Huang M, et al
    Super-enhancers promote transcriptional dysregulation in nasopharyngeal carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1143.2017.
    PubMed     Abstract available


  39. MATTOX A, Lee J, Westra WH, Pierce RH, et al
    PD-1 expression in head and neck squamous cell carcinomas derives primarily from functionally anergic CD4+ TILs in the presence of PD-L1+ TAMs.
    Cancer Res. 2017 Sep 25. pii: canres.3453.2016.
    PubMed     Abstract available


  40. KANSY BA, Concha-Benavente F, Srivastava RM, Jie HB, et al
    PD-1 status in CD8+ T cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer.
    Cancer Res. 2017 Sep 13. pii: canres.3167.2016.
    PubMed     Abstract available


  41. LAU MC, Ng KY, Wong TL, Tong M, et al
    FSTL1 promotes metastasis and chemoresistance in esophageal squamous cell carcinoma through NFkappaB-BMP signaling crosstalk.
    Cancer Res. 2017 Sep 7. pii: canres.1411.2017.
    PubMed     Abstract available


    July 2017
  42. EDWARDS ZC, Trotter EW, Torres-Ayuso P, Chapman P, et al
    Survival of head and neck cancer cells relies upon LZK kinase-mediated stabilization of mutant p53.
    Cancer Res. 2017 Jul 31. pii: canres.0267.2017.
    PubMed     Abstract available


    June 2017

  43. Correction: Connective Tissue Growth Factor Activates Pluripotency Genes and Mesenchymal-Epithelial Transition in Head and Neck Cancer Cells.
    Cancer Res. 2017;77:3127.
    PubMed    



  44. Correction: Chromosome Instability Modulated by BMI1-AURKA Signaling Drives Progression in Head and Neck Cancer.
    Cancer Res. 2017;77:3125-3126.
    PubMed    


    May 2017
  45. PRAT A, Navarro A, Pare L, Reguart N, et al
    Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma and melanoma.
    Cancer Res. 2017 May 9. pii: canres.3556.2017.
    PubMed     Abstract available


  46. HUANG D, Song S, Wu ZZ, Wu W, et al
    Epstein-Barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages.
    Cancer Res. 2017 May 8. pii: canres.2706.2016.
    PubMed     Abstract available


  47. TAMURA T, Ichikawa T, Nakahata S, Kondo Y, et al
    Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential.
    Cancer Res. 2017;77:2363-2374.
    PubMed     Abstract available


    April 2017
  48. ZOU M, Baitei EY, BinEssa HA, Al-Mohanna FA, et al
    Cyp24a1 Attenuation Limits Progression of BrafV600E -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720.
    Cancer Res. 2017;77:2161-2172.
    PubMed     Abstract available


    February 2017
  49. CHIU GS, Maj MA, Rizvi S, Dantzer R, et al
    Pifithrin-mu Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function.
    Cancer Res. 2017;77:742-752.
    PubMed     Abstract available


    January 2017
  50. TANG Q, Cheng B, Xie M, Chen Y, et al
    Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma.
    Cancer Res. 2017;77:532-544.
    PubMed     Abstract available


  51. ZHENG LS, Yang JP, Cao Y, Peng LX, et al
    SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor.
    Cancer Res. 2017;77:579-589.
    PubMed     Abstract available


    April 2016
  52. LI L, Li C, Wang S, Wang Z, et al
    Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype.
    Cancer Res. 2016;76:1770-80.
    PubMed     Abstract available


  53. JOLLY LA, Novitskiy S, Owens P, Massoll N, et al
    Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss.
    Cancer Res. 2016;76:1804-13.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: